HC Wainwright Expects Weaker Earnings for Alto Ingredients

Alto Ingredients, Inc. (NASDAQ:ALTO) – Equities research analysts at HC Wainwright lowered their Q3 2026 earnings per share (EPS) estimates for shares of Alto Ingredients in a research note issued to investors on Thursday, August 6th. HC Wainwright analyst A. Dayal now anticipates that the company will post earnings of $0.07 per share for the quarter, down from their previous forecast of $0.19. HC Wainwright has a “Buy” rating on the stock. The consensus estimate for Alto Ingredients’ current full-year earnings is $0.39 per share. HC Wainwright also issued estimates for Alto Ingredients’ Q4 2026 earnings at $0.12 EPS, FY2026 earnings at $0.39 EPS and FY2027 earnings at $0.28 EPS.

A number of other equities analysts have also issued reports on the stock. Zacks Research lowered shares of Alto Ingredients from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Weiss Ratings restated a “hold (c)” rating on shares of Alto Ingredients in a research report on Friday, July 31st. Finally, Scotiabank set a $10.00 price target on shares of Alto Ingredients in a research note on Thursday. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $10.00.

Alto Ingredients Price Performance

Shares of NASDAQ ALTO opened at $4.23 on Monday. Alto Ingredients has a fifty-two week low of $0.92 and a fifty-two week high of $6.11. The firm’s 50-day simple moving average is $5.23 and its 200 day simple moving average is $4.47. The company has a quick ratio of 2.54, a current ratio of 3.81 and a debt-to-equity ratio of 0.29. The stock has a market cap of $327.78 million, a P/E ratio of 6.31 and a beta of 0.17.

Alto Ingredients (NASDAQ:ALTO) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.07. The company had revenue of $245.70 million during the quarter, compared to analysts’ expectations of $231.24 million. Alto Ingredients had a return on equity of 18.94% and a net margin of 5.51%.

Institutional Trading of Alto Ingredients

Institutional investors have recently modified their holdings of the company. Hillsdale Investment Management Inc. grew its stake in shares of Alto Ingredients by 590.1% in the 1st quarter. Hillsdale Investment Management Inc. now owns 1,000,703 shares of the company’s stock worth $4,843,000 after purchasing an additional 855,703 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Alto Ingredients by 67.9% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,790,263 shares of the company’s stock valued at $8,665,000 after purchasing an additional 723,996 shares during the last quarter. Walleye Capital LLC acquired a new stake in Alto Ingredients during the first quarter valued at approximately $2,253,000. Hamilton Capital Partners LLC bought a new stake in Alto Ingredients during the fourth quarter worth approximately $577,000. Finally, Signet Private Wealth LLC bought a new stake in Alto Ingredients during the fourth quarter worth approximately $261,000. Institutional investors and hedge funds own 42.44% of the company’s stock.

Alto Ingredients Company Profile

Alto Ingredients, Inc (NASDAQ: ALTO) is a diversified producer of alcohol-based products and specialty ingredients for industrial, food, beverage and personal care applications. The company’s core offering centers on ethanol produced for fuel markets, as well as an expanding portfolio of natural and organic alcohols, glycerin and other ingredient solutions. Alto’s product lines serve a range of end markets, including renewable fuels, confectionery, flavorings, cosmetics and sanitizers.

Headquartered in Dallas, Texas, Alto Ingredients operates a network of production facilities across the United States.